Enamel Matrix Derivative
On this page
Direct answer
Enamel matrix derivative is a commercial gel of proteins extracted from porcine developing tooth germ, roughly 90 per cent amelogenins, applied to a conditioned root surface during periodontal surgery. Its biological premise is developmental: the enamel matrix proteins that Hertwig's epithelial root sheath secretes before cementum formation are believed to signal periodontal ligament cells to produce acellular cementum on the root, so re-creating that signal on a diseased root is proposed to mimic the natural attachment sequence. The root is conditioned with a neutral 24 per cent EDTA gel to lift the smear layer, then the derivative is applied immediately. Systematic reviews credit it with roughly a millimetre of additional attachment gain over controls in intrabony defects, with outcomes broadly comparable to guided tissue regeneration — minus the membrane, the tenting problem and any removal surgery.
What you must remember
- Composition: porcine enamel matrix proteins, approximately 90 per cent amelogenins (with ameloblastin, enamelin and enzymes as the remainder) in a propylene glycol alginate carrier.
- Developmental logic: enamel matrix proteins precede and direct acellular cementum formation on the developing root; the derivative attempts to replay that chapter on a diseased adult root.
- Protocol sequence: flap access (preferably papilla-preserving), thorough defect and root debridement, conditioning with neutral 24 per cent EDTA gel (PrefGel-type agents) to remove the smear layer, rinse and dry, apply the gel to the root and fill the defect, then primary closure.
- Why EDTA and not citric acid: neutral EDTA exposes root collagen without the caustic denaturation and protein coagulation of low-pH conditioning, preserving a surface ligament cells can colonise.
- Indications: deep, narrow intrabony defects (two to three walls) in good plaque control patients; also used with coronally advanced flaps to support root coverage.
- Limitation: no space-making capacity — in wide or shallow defects it supplies signals but no scaffold, which is why it is often combined with a bone graft where volume is needed.
- Evidence position: additional clinical attachment gain of about 1 mm over controls in systematic reviews of intrabony defects; comparable to GTR in head-to-head synthesis, without a second surgery for membrane removal.
- Practical virtue: technically forgiving — no membrane to expose, no removal visit, and technique-sensitivity lower than barrier methods.
One defect, treated with the protein logic
Take the same deep, narrow 8 mm three-wall intrabony defect between 46 and 47 that would suit GTR, and run the enamel matrix derivative sequence. After papilla-preserving access and meticulous debridement, the crucial minutes arrive: 24 per cent EDTA gel is painted on the root for the manufacturer's short conditioning time, then rinsed off with saline and the surface gently dried — the smear layer lifts, collagen is exposed, and the stage is set. The amelogenin gel flows over the root surface and into the defect; the flap is replaced and closed primarily. Nothing is removed later; nothing protrudes to expose. The wound-healing race is unchanged — epithelium still migrates fast — so closure quality and clot stability carry the outcome, which is why the same papilla-preservation discipline governs this technique. At the one-year re-evaluation, gains of a few millimetres of attachment in such deep defects are the realistic expectation, with reviews placing the incremental benefit near a millimetre over surgery alone. In a wider defect, add the graft under the gel: the protein supplies signal, the graft supplies space.
Where the exam frames it
Composition questions want "amelogenin, approximately 90 per cent, porcine origin" — the single most repeated fact. Protocol items test the EDTA conditioning step and its purpose (smear layer removal at neutral pH), and distinguish it from citric acid's harsher chemistry. Indication questions contrast derivative and membrane: comparable outcomes in intrabony defects, but no removal surgery, no exposure management, and no intrinsic space-making — the last point being the favourite discriminator for combined-technique questions. Mechanism stems reward the developmental answer: acellular cementum formation guided by enamel matrix proteins, as in tooth development, rather than a barrier excluding cells.
Frequently asked questions
What is enamel matrix derivative composed of?
A gel of porcine enamel matrix proteins, roughly 90 per cent amelogenins, applied to conditioned root surfaces during surgery.
Why is the root conditioned with 24 per cent EDTA before application?
Neutral EDTA removes the smear layer and exposes root collagen without caustic injury, creating a surface that periodontal ligament cells can recolonise.
What developmental process does the derivative attempt to mimic?
The formation of acellular cementum, which enamel matrix proteins from Hertwig's epithelial root sheath normally precede and direct.
How does its evidence compare with guided tissue regeneration?
Broadly comparable attachment gains in intrabony defects, with systematic reviews suggesting roughly a millimetre of additional attachment over controls.
Why is enamel matrix derivative often combined with a bone graft?
The gel provides biological signalling but no mechanical space; a graft beneath it supplies the scaffold that wide or shallow defects need.